Status:
COMPLETED
A Trial Of Azithromycin SR For The Treatment Of Laryngopharyngitis or Tonsillitis or Acute Bacterial Rhinosinusitis
Lead Sponsor:
Pfizer
Conditions:
Upper Respiratory Tract Infection
Eligibility:
All Genders
16-80 years
Phase:
PHASE3
Brief Summary
To evaluate the clinical efficacy and safety in patients with Laryngopharyngitis or Tonsillitis or Acute Bacterial Rhinosinusitis receiving a dose of 2 g of azithromycin in the SR formulation.
Eligibility Criteria
Inclusion
- Patients who were diagnosed Laryngopharyngitis or Tonsillitis or Acute Bacterial Rhinosinusitis
Exclusion
- Severe underlying disease; patients in which drug clinical evaluation is difficult because of confounding diseases.
Key Trial Info
Start Date :
November 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2007
Estimated Enrollment :
99 Patients enrolled
Trial Details
Trial ID
NCT00393835
Start Date
November 1 2006
End Date
May 1 2007
Last Update
May 16 2008
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer Investigational Site
Gobō, Wakayama, Japan, 644-8655
2
Pfizer Investigational Site
Hashimoto, Wakayama, Japan, 648-0053
3
Pfizer Investigational Site
Shinjo-cho, Tanabe, Wakayama, Japan, 646-8588
4
Pfizer Investigational Site
Wakayama, Wakayama, Japan, 640-8435